Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
About Cadila Pharmaceuticals Limited Cadila Pharmaceuticals Ltd., established in 1951, is a true Life Sciences company and over the years has emerged as the undisputed leader with largest range of therapeutic groups. The company covers the entire gamut of pharmaceuticals
HISTORY
They are from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, photochemistry and different disciplines of engineering It has a multicultural, multilingual and multinational workforce of more than 4000 employee including 200 people out side Indian 49countries of Africa,CIS,Japan,USA First Indian company to get IND approval by USFDA It has four more INDs with USDFA One for pulmonary tuberculosis, rest for various type of cancer, e.g., Lung cancer, Prostrate cancer, Bladder cancer and Melanoma
MILESTONE
Best research and development set-ups in the country Host of BIOTECH product launched Worlds first manufacture of immuvac-a unique immunomodulator USFDA approvals for fluoxetine and Ethambutol manufacturing facilities Asias only manufacture of SULFOLANE(tetramethylene sulfone) Leadership in domestic marketing and distribution management
INTERNATIONAL BUSINESS
A significant presence in the Americas, CIS country, Africa, Central and South-east Asia, Oceanic countries, Japan, Middle East and Europe It has offices in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan and ukrain International SBU plans to expand operations to more than 100 countries by 2010 Focus is on building brands in the following therapeutic segments: Anti-infective, Gastrointestinal, Analgesic, Respiratory, Cardiovascular, Ophthalmology, Bio-tchnical products
PRODUCT CAPACITY
MAIN PHARMA PRODOTION CAPACITY Tablets: 3900 million/year Capsules: 150 million/year Liquid: 6000 million kilolitres/year Sterile vias: 84 million/year Ampoules: 84 million/year Granules: 15.6 tones/year
BETA LACTUM /CEPHALOSPORIN Dry sterile vials: 48 million/year Dry syrup bottles: 27 million/year Capsules: 630 million/year Tablets: 510million/year
CHAMPION BRAND
ENVAS ACILOC LMX, SYMBIOTIK,CLAX RABELOC ACILOC RD, ZASO MIXULIN,MONTELAST,NODON First company in INDIA to introduce RABEPRAZOLE and FOSINPRIL formulations
PRODUCT
It caters to over 50 therapeutic areas Cardiovascular, gastrointestinal, analgesics, haematinics, anti-invectives and antibiotics, respiratory agents, antidiabetics and immunological Biotechonolgy products and digonontic kits, plants tissue culture Rabies immunoglobin and diagnostic kits for detection of HIV and HCV Companies also manufacturer tablet presses,capsule filling machine,pharma machinery parts and hospital disposables like gloves
MARKETING DIVISIONS
Magna-Practitioners, physicians, surgeons cardiologists, gastroenterologists Maxima-Chest physians, Dentists, surgeons Volta-cardiology, diabetology, nephrology, critical care Oncocare cadigran, caditrex,karplat,
THANK YOU